http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0213826-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d24f9fab6c793968c5f1c37ccb7d6992
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_882617d16a649ad82f5c20ed9eb4b738
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3f9d4dbe846176943642481c73d5ea39
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-243
filingDate 2001-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2716d7f3ee16b5db4f8328c026f3892
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_036b0de7005792c1242b6eeccdc24666
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a39838d5d0b466b2f5b5236adfba302
publicationDate 2002-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0213826-A1
titleOfInvention Anti-cancer composition composed of anti-cancer and anti-malarial drugs
abstract The present invention relates to complex compositions of anticancer drugs, which are administrated in combination with antimalarial drugs for reducing a minimum IC50 of anticancer drugs and inhibiting development of drug resistance of cancer cells caused by anticancer drugs, thereby enhancing the effect of the anticancer drugs. More particularly, the present invention relates to complex compositions of anticancer drugs, which are administrated in combination with antimalarial drugs for a minimun IC50 of anticancer drugs and inhibiting development of drug resistance of cancer cells caused by anticancer drugs, thereby enhancing the effect of the anticancer drugs; in which the anticancer drugs are selected from the group consisting of doxorubicin, cisplatin, and the like and the antimalarial drugs are selected from the group consisting of hydroxchloroquine, chloroquine, primaquine and the like.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102481253-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019138203-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102481252-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9023861-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8506973-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2465494-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008038291-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2465494-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014052550-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011076547-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2012201742-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012095045-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2764175-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-3076711-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021105761-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102481253-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7160692-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7279290-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7108992-B2
priorityDate 2000-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395500
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399906
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID773
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400121
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395949
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443939
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396057
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36462
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395948
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5978
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395833
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411305
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129233874
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54226752
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284558
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID249332
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135789409
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6274
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399905
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395834
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID457193
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395486
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395485
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19649
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5816
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4908
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2520
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129019136
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136202233
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21584101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396147
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396146
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396288
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733526
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395919
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID30323
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396287
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414731
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402323
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129756062
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3032583
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414730
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395471
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7108
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395470
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136079170
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64965
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3044368
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129589511
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID247704
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406888
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3034034
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2719
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395318
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136238575
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6328027
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136126664
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411304
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3652
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57272424

Total number of triples: 106.